RDY · Dr Reddys Laboratories Ltd
$11.80
-0.01 (-0.04%)
At close · Jul 24
Market Cap
$9.82B
Shares
833.00M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-07-23 | — | |
| 6-K | 2026-07-23 | — | |
| 6-K | 2026-07-23 | — | |
| 6-K | 2026-07-23 | — | |
| 6-K | 2026-07-23 | — | |
| 6-K | 2026-07-22 | — | |
| 6-K | 2026-07-22 | — | |
| 6-K | 2026-07-22 | — | |
| 6-K | 2026-07-22 | — | |
| 6-K | 2026-07-22 | — | |
| 6-K | 2026-07-15 | — | |
| 6-K | 2026-07-13 | — | |
| 6-K | 2026-07-10 | — | |
| 6-K | 2026-07-09 | — | |
| 6-K | 2026-07-01 | 2026-06-30 | |
| 6-K | 2026-07-01 | — | |
| 6-K | 2026-06-30 | — | |
| 6-K | 2026-06-30 | — | |
| 6-K | 2026-06-30 | — | |
| 6-K | 2026-06-26 | 2026-06-25 | |
| 6-K | 2026-06-22 | 2026-06-20 | |
| 6-K | 2026-06-22 | — | |
| 6-K | 2026-06-22 | 2026-06-19 | |
| 6-K | 2026-06-15 | 2026-06-13 | |
| 6-K | 2026-06-10 | — | |
| 6-K | 2026-06-05 | — | |
| 6-K | 2026-06-03 | — | |
| 6-K | 2026-06-01 | — | |
| 6-K | 2026-06-01 | 2026-05-30 | |
| 20-F | 2026-05-29 | 2026-03-31 | |
| 6-K | 2026-05-28 | — | |
| 6-K | 2026-05-28 | — | |
| 6-K | 2026-05-18 | 2026-05-16 | |
| 6-K | 2026-05-18 | — | |
| 6-K | 2026-05-15 | — | |
| 6-K | 2026-05-12 | — | |
| 6-K | 2026-05-12 | 2026-05-11 | |
| 6-K | 2026-05-12 | — | |
| 6-K | 2026-05-12 | — | |
| 6-K | 2026-05-12 | — | |
| 6-K | 2026-05-11 | — | |
| 6-K | 2026-04-29 | — | |
| 6-K | 2026-04-24 | — | |
| 6-K | 2026-04-24 | — | |
| 6-K | 2026-04-16 | — | |
| 6-K | 2026-04-15 | 2026-04-14 | |
| 6-K | 2026-04-08 | 2026-04-07 | |
| 6-K | 2026-03-26 | — | |
| 6-K | 2026-03-24 | — | |
| 6-K | 2026-03-23 | — |
Showing 1–50 of 720 filings
Key facts
CIK
1135951
CUSIP
256135203
13F (30d)
45 filings
45 filers
Visit website
Investor relations